NCT00071604

Brief Summary

This study will determine whether Medication Adherence Therapy (MAT) can improve medication adherence and lower the risk of rehospitalization in older patients with psychosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2002

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2002

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

October 29, 2003

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 30, 2003

Completed
3.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2007

Completed
Last Updated

May 6, 2013

Status Verified

April 1, 2008

First QC Date

October 29, 2003

Last Update Submit

May 3, 2013

Conditions

Interventions

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • DSM-IV criteria for schizophrenia or schizoaffective disorder
  • Outpatient status at the time of enrollment
  • Currently prescribed maintenance treatment with antipsychotic medication (typical or atypical, oral or depot)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division of Geriatric Psychiatry Center (University of California, San Diego)

San Diego, California, 92161, United States

Location

MeSH Terms

Conditions

Psychotic DisordersSchizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Jonathan Lacro, PharmD

    VA San Diego Healthcare System & University of California, San Diego

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 29, 2003

First Posted

October 30, 2003

Study Start

September 1, 2002

Study Completion

May 1, 2007

Last Updated

May 6, 2013

Record last verified: 2008-04

Locations